Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2006
NCT00965471
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Traditional Chinese Medicine Hospital of Xinjiang

Active Ingredients

Drugs in Phase 4 Trials (1)

interferon alpha-2b (Intron-A) (1 trial)

Drugs in Other Trials (2)

ginseng (1 trial)

pinellia (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3